10.34
Schlusskurs vom Vortag:
$10.58
Offen:
$10.62
24-Stunden-Volumen:
363.30K
Relative Volume:
0.77
Marktkapitalisierung:
$1.46B
Einnahmen:
$6.32B
Nettoeinkommen (Verlust:
$230.14M
KGV:
10.77
EPS:
0.9598
Netto-Cashflow:
$256.03M
1W Leistung:
-2.82%
1M Leistung:
-4.44%
6M Leistung:
+20.79%
1J Leistung:
-21.96%
Ardent Health Inc Stock (ARDT) Company Profile
Firmenname
Ardent Health Inc
Sektor
Branche
Telefon
(615) 296-3000
Adresse
340 SEVEN SPRINGS WAY, BRENTWOOD
Compare ARDT vs HCA, THC, EHC, FMS, DVA
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
|
ARDT
Ardent Health Inc
|
10.34 | 1.49B | 6.32B | 230.14M | 256.03M | 0.9598 |
|
HCA
Hca Healthcare Inc
|
426.74 | 94.31B | 76.39B | 7.81B | 7.93B | 29.08 |
|
THC
Tenet Healthcare Corp
|
255.56 | 20.91B | 21.46B | 2.65B | 3.35B | 19.23 |
|
EHC
Encompass Health Corp
|
121.49 | 12.18B | 6.07B | 793.80M | 464.40M | 5.9914 |
|
FMS
Fresenius Medical Care Ag Adr
|
22.38 | 12.08B | 22.44B | 1.35B | 2.03B | 1.9002 |
|
DVA
Davita Inc
|
174.92 | 11.39B | 13.84B | 1.10B | 1.49B | 10.42 |
Ardent Health Inc Stock (ARDT) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2025-11-17 | Herabstufung | KeyBanc Capital Markets | Overweight → Sector Weight |
| 2025-11-14 | Herabstufung | Morgan Stanley | Overweight → Equal-Weight |
| 2025-10-14 | Eingeleitet | Goldman | Neutral |
| 2025-09-10 | Eingeleitet | UBS | Buy |
| 2025-07-16 | Herabstufung | BofA Securities | Neutral → Underperform |
| 2024-12-17 | Fortgesetzt | JP Morgan | Neutral |
| 2024-11-06 | Herabstufung | BofA Securities | Buy → Neutral |
| 2024-10-11 | Eingeleitet | KeyBanc Capital Markets | Overweight |
| 2024-08-12 | Eingeleitet | BofA Securities | Buy |
| 2024-08-12 | Eingeleitet | Citigroup | Buy |
| 2024-08-12 | Eingeleitet | JP Morgan | Neutral |
| 2024-08-12 | Eingeleitet | Leerink Partners | Outperform |
| 2024-08-12 | Eingeleitet | Loop Capital | Buy |
| 2024-08-12 | Eingeleitet | Mizuho | Outperform |
| 2024-08-12 | Eingeleitet | Morgan Stanley | Overweight |
| 2024-08-12 | Eingeleitet | RBC Capital Mkts | Outperform |
| 2024-08-12 | Eingeleitet | Stephens | Overweight |
| 2024-08-12 | Eingeleitet | Truist | Buy |
Alle ansehen
Ardent Health Inc Aktie (ARDT) Neueste Nachrichten
Ardent Health, Inc. (NYSE:ARDT) Stock Has Consensus Target Price of $12.79 According to Brokerages - marketbeat.com
Bronstein, Gewirtz & Grossman, LLC Is Investigating Ardent Health, Inc. (ARDT) And Encourages Shareholders to Connect - ACCESS Newswire
BMO Capital Initiates Ardent Health With Market Perform Rating, $11 Price Target - Moomoo
Ardent Health Price Target Announced at $11.00/Share by BMO Capital - Moomoo
BMO initiates Ardent Health stock with Market Perform rating By Investing.com - Investing.com Australia
BMO initiates Ardent Health stock with Market Perform rating - Investing.com
Bronstein, Gewirtz & Grossman, LLC Announces an Investigation Against Ardent Health, Inc. (ARDT) and Encourages Investors to Learn More About the Investigation - ACCESS Newswire
Top Ardent Health (ARDT) Competitors 2026 - MarketBeat
Is the Options Market Predicting a Spike in Ardent Health Stock? - Yahoo Finance
Ardent Health Hospitals Earn Recognition in U.S. News & World Report’s 2026-2027 Best Hospitals Rankings - Yahoo Finance
HealthStream launches hStream platform, partners with Ardent Health - The Business Journals
Health systems now have a third enterprise system for clinical workers, HealthStream says - Stock Titan
Ardent Health at wells fargo healthcare conference: margin push gains pace - Investing.com Canada
Ardent Health (ARDT) Gains 0.93% to $10.85 as Shares Hold Above SupportMomentum Surge Alerts - dars.gov.et
Ardent Health (ARDT) Edges Higher: Range-Bound as Support and Resistance HoldRevenue Growth Stocks - siam.in
How Ardent Health uses joint ventures to grow - Private Equity Stakeholder Project PESP
Ardent Health Adjusts 2025 EBITDA and EBITDAR Figures Ahead of Future Filings - Kalkine Media
Bronstein, Gewirtz & Grossman, LLC Encourages Ardent Health, Inc. (ARDT) Investors to Inquire about Securities Investigation - ACCESS Newswire
2026-09-06 | Bronstein, Gewirtz & Grossman, LLC Encourages Ardent Health, Inc. (ARDT) Investors to Inquire about Securities Investigation | NYSE:ARDT | Press Release - stockhouse.com
ARDT News | ARDENT HEALTH INC (NYSE:ARDT) - ChartMill
Ardent Health Adjusts 2025 Non-GAAP EBITDA and EBITDAR Following SEC Review - Kalkine Media
Ardent Health revises 2025 Adjusted EBITDA to $447.3M, Adjusted EBITDAR to $611.6M after removing $97.7M of non‑GAAP adjustments - TradingView
Is Ardent Health (ARDT) Cheap As UT Tyler Expansion Lifts Its Long Term Outlook? - simplywall.st
Bronstein, Gewirtz & Grossman, LLC Initiates an Investigation into Allegations Against Ardent Health, Inc. (ARDT) And Encourages Investors to Reach Out - ACCESS Newswire
Ardent Health Marks Expansion of Specialty Care in New UT Tyler School of Medicine - Business Wire
Ardent Health (ARDT) Q2 2026 Earnings: EPS Misses Estimates by 35.06% as Stock Edges UpConsensus Forecast Report - dars.gov.et
Bronstein, Gewirtz & Grossman, LLC Is Investigating Ardent Health, Inc. (ARDT) And Encourages Stockholders to Connect - ACCESS Newswire
Ardent Health (NYSE: ARDT) ex-officer plans $398K stock sale - Stock Titan
ARDT Stock News Today | Earnings, Events & Price Alerts - Intellectia AI
Former Ardent Health (NYSE: ARDT) leader lines up new share sale after August trades - Stock Titan
Did You Lose Money Investing in Ardent Health, Inc.? If so, Conta - The National Law Review
Ardent Health (NYSE: ARDT) ex-exec lines up six-figure stock sale - Stock Titan
Ardent Health’s BSA Health System partners with Cardiology Center of Amarillo to expand heart care access - Bitget
Ardent Health (NYSE: ARDT) ex-exec lines up 2026 sale of stock grants - Stock Titan
Sei Investments Co. Lowers Stock Holdings in Ardent Health, Inc. $ARDT - MarketBeat
Bronstein, Gewirtz & Grossman, LLC Encourages Ardent Health, Inc. (ARDT) Stockholders to Inquire about Securities Investigation - ACCESS Newswire
2026-08-16 | Bronstein, Gewirtz & Grossman, LLC Encourages Ardent Health, Inc. (ARDT) Stockholders to Inquire about Securities Investigation | NYSE:ARDT | Press Release - Stockhouse
ARDT Q2 2026 Earnings: EPS Misses Estimates by 35.06% as Stock DeclinesFinal Results - vinanet.vn
Why Ardent Health (ARDT) Is Down 5.5% After Cutting 2026 Guidance And Fueling Options JittersAnd What's Next - simplywall.st
Wedge Capital Management L L P NC Acquires 222,447 Shares of Ardent Health, Inc. $ARDT - MarketBeat
Implied Volatility Surging for Ardent Health Stock Options - TradingView
Ardent Health Services Number of Employees 2026 | Employee Count & Headcount Data - Revelio Labs
Ardent Health (ARDT) Q2 2026 Earnings Call Transcript - AOL.com
Ardent Health, Inc. (ARDT) Investigation: Bronstein, Gewirtz & Grossman, LLC Encourages Shareholders to Contact the Firm to Learn More About the Investigation - ACCESS Newswire
ARDT WRITE OFFS: Hagens Berman Investigating Claims Against Ardent Health (ARDT) Over Alleged $97M Accounting Shock and "180-Day Cliff" Reserves (PR Newswire) - Aktiellt
A next-generation heart pump is tested during high-risk stenting - Stock Titan
Ardent Health, Inc. (ARDT) Stock Analysis: Exploring a 13.84% Potential Upside for Investors - DirectorsTalk Interviews
Ardent Health (ARDT) Falls 4.24% to $11.06, Approaches Key $10.51 SupportMESA MA - dars.gov.et
RBC Capital raises Ardent Health stock price target on EBITDA beat By Investing.com - Investing.com Australia
RBC Capital raises Ardent Health stock price target on EBITDA beat - Investing.com India
Ardent Moves on From Managers, Bumps Cost-Cutting Plan to $70M+ - HCI Innovation Group
Finanzdaten der Ardent Health Inc-Aktie (ARDT)
Umsatz
Nettogewinn
Free Cashflow
ENV
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):